期刊文献+

华法林联合阿司匹林治疗对川崎病合并巨大冠状动脉瘤预后的影响 被引量:15

Warfarin and aspirin combination therapy for giant coronary artery aneurysm secondary to Kawasaki disease
原文传递
导出
摘要 目的探索华法林联合阿司匹林治疗对KD合并巨大冠状动脉瘤(GCAA)预后的影响,为改善KD合并GCAA患儿的预后提供临床依据。方法选取1998年1月至2012年8月首都医科大学附属北京儿童医院超声心动图诊断为KD合并GCAA的患儿65例。将患儿分为华法林+阿司匹林组及阿司匹林组。华法林+阿司匹林组采用小剂量阿司匹林联合华法林的治疗方案,阿司匹林组采用小剂量阿司匹林治疗方案,但不使用华法林。入组患儿分别于急性期出院后2周、1个月、3个月、6个月、1年复诊,1年以后每6个月复诊1次。随访其临床表现、冠状动脉瘤恢复情况及并发症发生情况。结果(1)KD合并GCAA患儿的发病年龄最小为3个月,最大为13岁3个月,其中≤1岁的小婴儿和/〉5岁的儿童所占比例较高,均为23.1%。(2)2组患儿冠状动脉各分支的GCAA分布情况一致。GCAA最常累及右冠状动脉,其次为左冠状动脉前降支,再次为左冠状动脉主干,较少累及左冠状动脉回旋支。(3)华法林+阿司匹林组有17例(53.1%)出现回缩趋势,阿司匹林组为5例(41.7%)。华法林+阿司匹林组有15例(46.9%)患儿的冠状动脉瘤内径无明显变化,阿司匹林组为7例(58.3%)。(4)华法林+阿司匹林组有2例(6.3%)发生冠状动脉内血栓,阿司匹林组为3例(25,O%)。华法林+阿司匹林组有1例(3.1%)发生心肌梗死,阿司匹林组为3例(25.0%)。阿司匹林组有2例(16.7%)死亡,而华法林+阿司匹林组无死亡病例。阿司匹林组有2例(16.7%)发生冠状动脉狭窄,1例(3.1%)发生冠状动脉闭塞,华法林+阿司匹林组有1例发生冠状动脉狭窄,但未出现冠状动脉闭塞。(5)华法林+阿司匹林组有1例发生严重出血事件,为蛛网膜下腔出血。另外,有8例出现鼻出血,共19例次。阿司匹� Objective To explore whether the warfarin and aspirin combination therapy can prevent cardiovascular events in patients with giant coronary artery aneurysm (GCAA) caused by Kawasaki disease (KD). Methods Children who had been diagnosed as GCAA secondary to KD in Beijing Children's Hospital Affiliated to Capital Medical University between Jan. 1998 and Aug. 2012 were enrolled in this study. They were divided into the warfarin plus aspirin group ( combination group) and aspirin group. The combination group used the therapy of warfarin and small dose aspirin in the long-term anticoagulation treatment, while the aspirin group used small dosage of aspirin without warfarin. Both groups were followed at the time points of 2^nd week, 1^st month ,3^rd month,6^th month, and 1^st year after discharge of the acute stage. Then these children were followed every 6 months. Data on each followed-up included clinical manifestations, coronary artery aneurysm recovery situation and complications. Results ( 1 ) The onset age of GCAA caused by KD ranged from 3 months to 13 years and 3 months. Infants who were ≤ 1 year old and children who were ≥5 years old were more susceptible to this disease, their proportion were both 23.1% . (2) The distribution of GCAA in both groups were similar. GCAA most commonly occurred in the right coronary artery, then the left anterior descending coronary artery, and then the main trunk of left coronary artery, the left circumflex artery was rarely affected. ( 3 ) Coronary artery aneurysm in 17 cases(53.1% ) retracted in the warfarin combined with aspirin group,while 5 cases(41.7% ) in the aspirin group. Fifteen cases(46.9% ) in the combination group hadn't obvious change ,while the aspirin group got 7 cases(58.3% ). (4)During the follow-up,2 children(6.3% )complicated with intracoronary thromboses in the combination group,while 3 cases(25.0% ) in the aspirin group. One case(3.1% ) in the combination group suffered myocardi al infarction,whi
出处 《中华实用儿科临床杂志》 CAS CSCD 北大核心 2013年第9期649-652,共4页 Chinese Journal of Applied Clinical Pediatrics
基金 国家自然科学基金面上项目(81274109,30973238) 北京自然科学基金面上项目(7092032) 北京自然科学基金B类/北京教育委员会重大科研项目(KZ201010025024) 北京市教育委员会科技创新平台项目(PXM2011-014226-07-000085) 北京市卫生系统高层次卫生技术人才培养计划项目(2009-3-38)
关键词 川崎病 巨大冠状动脉瘤 华法林 抗凝治疗 预后 Kawasaki disease Giant coronary artery aneurysm Warfarin Anticoagulation therapy Prognosis
  • 相关文献

参考文献19

  • 1Rosa GD,Cefalo MG,Marano R. Delayed diagnosis of Kawasaki syndrome and thrombosis of a medium-sized aneurysm of the anterior descending coronary artery:case report and literature review[J].Rheumatology International,2012,(03):809-814. 被引量:1
  • 2Suda K,Iemura M,Nishiono H. Long-term prognosis of patients with Kawasaki disease complicated by giant coronary aneurysms:a single-institution experience[J].Circulation,2011,(17):1836-1842. 被引量:1
  • 3Daniels LB,Tjajadi MS,Walford HH. Prevalence of Kawasaki disease in young adults with suspected myocardial ischemia[J].Circulation,2012,(20):2447-2453. 被引量:1
  • 4Tsuda E,Abe T,Tamaki W. Acute coronary syndrome in adult patients with coronary artery lesions caused by Kawasaki disease:review of case reports[J].Cardiology in the Young,2011,(01):74-82. 被引量:1
  • 5Salamat M,Khan MS. Ring-calcification of giant coronary artery aneurysm of an 11-year-old child with history of Kawasaki disease[J].Pediatric Cardiology,2010,(04):558-559. 被引量:1
  • 6Manlhiot C,Brandao LR,Somji Z. Long-term anticoagulation in Kawasaki disease:initial use of low molecular weight heparin is a viable option for patients with severe coronary artery abnormalities[J].Pediatric Cardiology,2010,(06):834-842. 被引量:1
  • 7Newburger JW,Takahashi M,Gerber MA. Diagnosis,treatment,and long-term management of Kawasaki disease:a statement for health professionals from the committee on rheumatic fever,endocarditis,and Kawasaki disease,council on cardiovascular disease in the young,American Heart Association[J].Pediatrics,2004,(06):1708-1733. 被引量:1
  • 8Japanese Circulation Society Joint Research Group. Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease[J].Pediatrics International,2005,(06):711-732. 被引量:1
  • 9Yanagawa H,Sonobe T. Changes in the diagnostic guidelines for Kawasaki disease[A].Tokyo:Shindan-To-Chiryo-sha,2004.23-32. 被引量:1
  • 10Sudo D,Monobe Y,Yashiro M. Case-control study of giant coronary aneurysms due to Kawasaki disease:the 19th nationwide survey[J].Pediatrics International,2010,(05):790-794. 被引量:1

同被引文献152

  • 1吴长鸿,刘斌.第四届全国脑血管病学术会议[J].中华医学信息导报,1996,0(6):4-4. 被引量:133
  • 2郑艳梅.川崎病儿童急性期凝血功能检测及分析[J].山西医科大学学报,2005,36(5):629-630. 被引量:1
  • 3黄敏.川崎病随访方案(试行)[J].临床儿科杂志,2006,24(5):427-428. 被引量:18
  • 4覃丽君,王宏伟,胡秀芬,刘清军,施虹,隈远祥,陈全景,程佩萱.静脉注射不同剂量丙种球蛋白治疗川崎病的临床研究[J].中华儿科杂志,2006,44(12):891-895. 被引量:40
  • 5郑晓红,罗本燕.急性脑血管病早期康复开始时间的研究[D].杭州:浙江大学硕士学位论文,2011. 被引量:1
  • 6Fukazawa R. Long-term prognosis of Kawasaki disease: increased cardiovascular risk? [J]. Curr Opin Pediatr, 2010,22(5) :587-592. 被引量:1
  • 7Newburger JW,Takahashi M, Gerber M A, et al. Diag- nosis, treatment, and long-term management of Ka- wasaki disease a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Dis- ease in the Young, American Heart Association[J]. Circulation,2004, 110(17):2 747-2 771. 被引量:1
  • 8JCS Joint Working Group. Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2008) digest version[J]. Circ J,2010,74 (9):1 989-2 020. 被引量:1
  • 9Paredes N, Mondal T, Brandao L R, et al. Management of myocardial infarction in children with Kawasaki dis- ease[J]. 131ood Coagul Fibrinolysis, 2010,21 (7) : 620- 631. 被引量:1
  • 10Nakamura Y,Aso E,Yashiro M,et al. Mortality among persons with a history of kawasaki disease in Japan: mortality among males with cardiac sequelae is signifi- cantly higher than that of the general population[J]. Circ J,2008,72(1) :134-138. 被引量:1

引证文献15

二级引证文献107

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部